Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Drugs in Tuberculosis and Leprosy
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drugs in Tuberculosis and Leprosy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
5-aminosalicylic Acid (5-ASA)
50%
Adverse Effect Profile
100%
Adverse Effects
50%
Aminoglycosides
50%
Bedaquiline
50%
Carbapenems
50%
Clofazimine
50%
Combination Regimen
50%
D-cycloserine
50%
Dapsone
50%
Delamanid
50%
Drug Adverse Effects
50%
Drug Interactions
50%
Ethambutol
50%
Fluoroquinolones
50%
In Incorporation
50%
Leprosy
100%
Linezolid
50%
Macrolides
50%
Novel Agents
50%
Patient Characteristics
50%
Polypeptide
50%
Pyrazinamide
50%
Rifamycin
50%
Terizidone
50%
Toxicity Profile
50%
Treatment Regimen
50%
Tuberculosis
100%
Tuberculosis Treatment
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
50%
Adverse Event
100%
Aminoglycoside
50%
Aminosalicylic Acid
50%
Bedaquiline
50%
Carbapenem Derivative
50%
Clofazimine
50%
Cycloserine
50%
Dapsone
50%
Delamanid
50%
Ethambutol
50%
Isoniazid
50%
Linezolid
50%
Macrolide
50%
Polypeptide
50%
Pyrazinamide
50%
Quinolone Derivative
50%
Rifamycin
50%
Terizidone
50%
Thioacetazone
50%